AtriCure (ATRC) Financials: History & Chart

AtriCure, Inc.(ATRC)

Medical - Instruments & Supplies · Mason, OH

$54.86-1.51 (-2.68%)

Delayed quote: Oct 6, 2026, 10:50 AM EDT

About AtriCure, Inc.

AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves. Its market reach spans the United States, Europe, Asia, and other international territories. The company's product line features various ablation technologies. These include Isolator Synergy Clamps, which are single-use radiofrequency products. Its multifunctional pens, such as the MAX Pen, uniquely enable surgeons to evaluate cardiac arrhythmias, conduct temporary pacing, sensing, and stimulation, and perform tissue ablation with a single device. The Coolrail device facilitates the creation of longer linear ablation lines. For varying lengths of linear ablations, the CryoICE Cryoablation System is available. Furthermore, the EPi-Sense Guided Coagulation System is a single-use solution for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. AtriCure also provides systems for cardiac appendage management and soft-tissue closure. The AtriClip System is an implantable device accompanied by a disposable applier, while the LARIAT System offers a suture-based solution for soft-tissue closure, compatible with various anatomical shapes. Additionally, AtriCure offers supplementary surgical tools including Lumitip Dissectors, designed to separate tissues for optimal access, Glidepath guides for precise clamp placement, and Subtle Cannulas facilitating access for EPi-Sense catheters. A suite of reusable cardiac surgery instruments, crucial for procedures involving heart valve repair or replacement, is also available. The company distributes its offerings through a combination of independent distributors and direct sales personnel. Founded in 2000, AtriCure maintains its headquarters in Mason, Ohio.

Mason, OH

1,350 employees

www.atricure.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Michael H. Carrel

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	569.62M	153.60M	141.25M	140.50M	134.27M	136.14M	123.62M	124.28M	115.91M
Cost of Goods Sold	135.77M	34.98M	31.94M	35.92M	32.94M	34.66M	30.99M	31.66M	29.12M
Gross Profit	433.85M	118.63M	109.31M	104.58M	101.33M	101.48M	92.63M	92.62M	86.79M
Gross Profit Margin	76.2%	77.2%	77.4%	74.4%	75.5%	74.5%	74.9%	74.5%	74.9%
Total Operating Expenses	419.96M	108.96M	108.78M	101.09M	101.12M	107.67M	98.58M	107.14M	94.20M
Research & Development	96.27M	26.40M	24.23M	22.75M	22.89M	29.28M	22.53M	34.96M	20.96M
Selling, General & Administrative	323.69M	82.56M	84.55M	78.34M	78.23M	78.39M	76.05M	72.19M	73.24M
Operating Income (EBIT)	13.89M	9.66M	526K	3.49M	208K	-6.19M	-5.95M	-14.52M	-7.41M
Operating Margin	2.4%	6.3%	0.4%	2.5%	0.2%	-4.5%	-4.8%	-11.7%	-6.4%
Income Before Tax (EBT)	12.09M	9.43M	394K	2.36M	-86K	-5.93M	-6.51M	-15.30M	-7.53M
Interest Income	5.74M	1.18M	1.25M	1.33M	1.98M	941K	1.04M	1.20M	1.28M
Interest Expense	7.07M	1.32M	1.34M	1.50M	2.91M	1.49M	1.42M	1.45M	1.67M
Other Income/Expense	-1.80M	-239K	-132K	-1.13M	-294K	263K	-554K	-779K	-126K
Net Income	10.55M	8.96M	108K	1.76M	-267K	-6.19M	-6.75M	-15.57M	-7.85M
Income Tax Expense	1.54M	471K	286K	604K	181K	261K	239K	266K	322K
Net Profit Margin	1.9%	5.8%	0.1%	1.2%	-0.2%	-4.5%	-5.5%	-12.5%	-6.8%
EBITDA	34.75M	14.97M	5.80M	8.60M	5.38M	-1.02M	-870K	-9.70M	-2.48M
EBITDA Margin	6.1%	9.7%	4.1%	6.1%	4.0%	-0.7%	-0.7%	-7.8%	-2.1%
Depreciation & Amortization	20.86M	5.31M	5.27M	5.11M	5.17M	5.17M	5.08M	4.83M	4.93M
EPS Basic	0.21	0.18	0.00	0.04	-0.01	-0.13	-0.14	-0.33	-0.17
EPS Diluted	0.21	0.18	0.00	0.04	-0.01	-0.13	-0.14	-0.33	-0.17
Weighted Average Basic Shares	48.50M	48.50M	48.33M	47.96M	47.68M	47.56M	47.39M	47.10M	47.10M
Weighted Average Diluted Shares	49.09M	49.09M	49.05M	48.87M	47.68M	47.56M	47.39M	47.10M	47.10M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	534.53M	465.31M	399.25M	330.38M	274.33M	206.53M	230.81M	201.63M
Cost of Goods Sold	136.79M	117.78M	98.88M	84.44M	68.47M	57.22M	60.47M	54.51M
Gross Profit	397.74M	347.52M	300.37M	245.94M	205.86M	149.31M	170.34M	147.12M
Gross Profit Margin	74.4%	74.7%	75.2%	74.4%	75.0%	72.3%	73.8%	73.0%
Total Operating Expenses	401.19M	387.54M	327.05M	288.61M	150.66M	193.54M	203.46M	164.25M
Research & Development	90.17M	96.18M	73.92M	57.34M	48.51M	43.07M	41.23M	34.72M
Selling, General & Administrative	311.02M	291.36M	253.14M	231.27M	204.65M	150.47M	162.23M	129.52M
Operating Income (EBIT)	-3.45M	-40.01M	-26.68M	-42.67M	55.20M	-44.23M	-33.12M	-17.13M
Operating Margin	-0.6%	-8.6%	-6.7%	-12.9%	20.1%	-21.4%	-14.4%	-8.5%
Income Before Tax (EBT)	-10.16M	-43.67M	-29.85M	-46.20M	50.39M	-48.04M	-34.99M	-20.91M
Interest Income	4.48M	4.43M	3.79M	1.99M	466K	1.10M	2.40M	1.01M
Interest Expense	5.88M	6.41M	6.92M	4.99M	4.92M	4.88M	4.11M	4.61M
Other Income/Expense	-6.72M	-3.66M	-3.16M	-3.53M	-4.82M	-3.81M	-1.87M	-3.78M
Net Income	-11.45M	-44.70M	-30.44M	-46.47M	50.20M	-48.16M	-35.19M	-21.14M
Income Tax Expense	1.28M	1.02M	591K	268K	188K	114K	199K	226K
Net Profit Margin	-2.1%	-9.6%	-7.6%	-14.1%	18.3%	-23.3%	-15.2%	-10.5%
EBITDA	17.08M	-21.28M	-11.87M	-30.96M	65.65M	-34.69M	-23.76M	-8.37M
EBITDA Margin	3.2%	-4.6%	-3.0%	-9.4%	23.9%	-16.8%	-10.3%	-4.2%
Depreciation & Amortization	20.53M	18.73M	14.81M	11.71M	10.44M	9.55M	9.37M	8.75M
EPS Basic	-0.24	-0.95	-0.66	-1.02	1.11	-1.14	-0.94	-0.62
EPS Diluted	-0.24	-0.95	-0.66	-1.02	1.09	-1.14	-0.94	-0.62
Weighted Average Basic Shares	47.75M	46.97M	46.31M	45.74M	45.07M	42.13M	37.59M	34.09M
Weighted Average Diluted Shares	47.75M	46.97M	46.31M	45.74M	46.04M	42.13M	37.59M	34.09M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.